PMCB Stock Analysis: Buy, Sell, or Hold?
PMCB - PharmaCyte Biotech, Inc. Common Stock
$0.82
-0.03 (-3.42%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 16, 2026
Get Alerted When PMCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called PMCB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PMCB is down 12.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PMCB is down 12.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PMCB is currently trading at $0.82, which is considered extended relative to its 30-day fair value range of $0.76 to $0.92.
Technical Outlook: Technically, PMCB is in a downtrend. Immediate support is located at $0.76, while resistance sits at $1.05. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMCB is in a downtrend. Immediate support is located at $0.76, while resistance sits at $1.05. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.76 -
$0.92
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
39.4%
Protect Your Profits
Holding PMCB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
Fair Price Analysis
30-Day Fair Range
$0.76 -
$0.92
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.76
Resistance Level
$1.05
Current Trend
Downtrend
Fundamental Context
Last updated: February 01, 2026 4:45 AM ET
Data refreshes hourly during market hours. Next update: 5:45 AM
Data refreshes hourly during market hours. Next update: 5:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMCB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced PMCB Option Strategies
Professional options setups generated by AI based on today's PMCB price and gamma walls.
